Detalles de la búsqueda
1.
Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer.
Invest New Drugs
; 28(3): 334-42, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19415181
2.
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.
Clin Cancer Res
; 15(2): 723-30, 2009 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19147780
3.
Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignancies.
Clin Cancer Res
; 15(10): 3591-9, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19417019
4.
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
Clin Cancer Res
; 13(9): 2675-83, 2007 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17473199
5.
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors.
Clin Cancer Res
; 11(24 Pt 1): 8728-36, 2005 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16361560
6.
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignancies.
J Clin Oncol
; 21(1): 148-57, 2003 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12506184
7.
A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies.
Clin Cancer Res
; 9(15): 5540-9, 2003 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14654534
8.
Phase I and pharmacokinetic study of sequential paclitaxel and trabectedin every 2 weeks in patients with advanced solid tumors.
Clin Cancer Res
; 16(9): 2656-65, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20406837
9.
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.
Invest New Drugs
; 25(4): 359-67, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17237909
Resultados
1 -
9
de 9
1
Próxima >
>>